Christian Marth, MD, PhD, discusses the differences between mismatch repair–deficient and –proficient subtypes of advanced/recurrent endometrial cancer and other research efforts of interest.
FDA Approves HPV Self-Collection Test for Cervical Cancer
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
Revisit Every OncLive On Air Episode From April 2024
Naumann Discusses Notable Research Efforts in Endometrial Cancer
FDA Grants Breakthrough Device Designation to At-Home Cervical Cancer Screening Test
Naumann Dives into Case-by-Case Decision-Making in Ovarian and Endometrial Cancer
Dr Liu Previews ASCO 2024 Lung Cancer Data
Dr Rajkumar Previews ASCO 2024 Data in Multiple Myeloma
Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer